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ABSTRACT 
Laura Taylor: Influence of Genetic Variance on Occupational Exposure 
to 1,6-Hexamethylene Diisocyanate Isocyanurate 
(Under the direction of Leena Nylander-French) 
  
Exposure to diisocyanates is a leading cause of occupational asthma around the world. 
We investigated the potential of genetic polymorphic markers to affect urine biomarker 
trisaminohexyl isocyanurate (TAHI) levels in 33 automotive spray-painters exposed to 1,6-
hexamethylene diisocyanate (HDI) isocyanurate, an oligomer of HDI. Genome-wide association 
analysis using a false discovery rate of q<0.20 indicated that one single nucleotide polymorphic 
(SNP) marker, rs12955846, was significantly associated with urine TAHI levels after controlling 
for four covariates (current smoking status, ethnicity, and inhalation and skin exposure to HDI 
isocyanurate). Linear mixed effects model showed that this SNP explained 70% of the 
biomarker variance. In bioinformatics evaluation, we identified and evaluated coding genes and 
potential regulatory elements that are proximal to the ten most influential SNPs. The 
methodology presented here has the potential to inform us on individual susceptibility factors 
that may affect biomarker levels of HDI isocyanurate exposure. 
  
 iv 
ACKNOWLEDGEMENTS 
First and foremost I want to thank Dr. Leena Nylander-French for supporting me; she 
has been a wonderful adviser and I am extremely appreciative of her guidance. Dr. Jef French 
provided me with great guidance as well on how to do the bioinformatics for this project. I am 
also thankful to Drs. Rebecca Fry and Ilona Jaspers for being on my thesis committee, and I 
want to acknowledge the professors in the toxicology curriculum for my pedagogical training. I 
also want to acknowledge Tiffany Bailey from Accessibility Resources and Services. I am very 
grateful for the work she put into making special arrangements for my courses so I could 
continue my training. I want to thank the UNC Environmental Sciences and Engineering 
program too for providing me with a Teaching Assistant position during my last semester as a 
toxicology student. Additionally, I could not have completed this year without the support and 
encouragement of my family and friends. In particular, my husband, Michael Taylor; mother, 
Ramona Word; father, Dr. Gary Word; and best friend, Lena Phalen, were all vital in helping me 
through my hardest times over the past year. 
Furthermore, this study would not have been possible without previous work by other 
students from Leena’s lab. Namely, Kathie Sun, who wrote the PLINK and SAS codes I used so 
the results are comparable to her parallel study on the biomarker for exposure to the 1,6-
hexamethylene diisocyanate monomer. The study would not have been possible without work 
by Zachary Robbins either, who quantified the biomarker levels for isocyanurate exposure by 
using the tandem mass spectrophotometry method he developed. Additionally, Kenneth Fent,  
 v 
Linda Gaines, Jennifer Thomasen, and Sheila Flack conducted the foundational testing and work 
for this research and study population. 
Lastly, I am appreciative of the funding that supported this research which was provided 
by a National Research Service Award T32 ES007126 from the National Institute of 
Environmental Health Sciences and by grants from the National Institute for Occupational 
Safety and Health (R21OH010203, R01-OH007598).  
 
 
 vi 
TABLE OF CONTENTS 
 
LIST OF TABLES .............................................................................................................................. viii 
LIST OF FIGURES .............................................................................................................................. ix 
LIST OF ABBREVIATIONS .................................................................................................................. x 
CHAPTER 1: INTRODUCTION ........................................................................................................... 1 
              Diisocyanates Overview ..................................................................................................... 1 
              Occupational Exposure to Diisocyanates ........................................................................... 3 
              Diisocyanate and Isocyanurate Metabolism and Biomarkers............................................ 4 
              Diisocyanate Health Effects and Evidence of Sensitization ................................................ 5 
              Changes in Gene Expression Following Diisocyanate Exposure ......................................... 6 
              Genetic Associations with Diisocyanate Asthma ............................................................... 7 
              Genetic Associations with Diisocyanate Biomarkers ......................................................... 7 
              Diisocyanate Knowledge Gaps ........................................................................................... 8 
CHAPTER 2: SPECIFIC AIMS ............................................................................................................. 9 
CHAPTER 3: METHODS .................................................................................................................. 10 
              Study Participants ............................................................................................................ 10 
              Assessment of Exposure and Biomarker Levels ................................................................ 10 
              Genotyping and Quality Control Procedures .................................................................... 12 
              Genome-Wide Association Study (GWAS) ........................................................................ 13
 vii 
              Candidate-Gene Analysis .................................................................................................. 15 
              Linear Mixed Effects Exposure Model .............................................................................. 16 
              Bioinformatics Analysis .................................................................................................... 17 
CHAPTER 4: RESULTS..................................................................................................................... 18 
              Exposure and Biomarker Levels ........................................................................................ 18 
              Genome-wide Analysis ..................................................................................................... 18 
              Candidate Gene Analysis .................................................................................................. 21 
              Bioinformatics .................................................................................................................. 22 
CHAPTER 5: DISCUSSION ............................................................................................................... 27 
              GWAS and Linear Mixed Effects Model ............................................................................ 27 
              Bioinformatics .................................................................................................................. 28 
              Limitations ........................................................................................................................ 31 
CHAPTER 6: CONCLUSIONS ........................................................................................................... 33 
APPENDIX A: PLINK CODE ............................................................................................................. 34 
APPENDIX B: SAS CODE ................................................................................................................. 35 
REFERENCES .................................................................................................................................. 38 
 
 viii 
LIST OF TABLES 
 
Table 1. Assigned protected factors for type of respiratory protection 
                worn by workers ............................................................................................................. 12 
Table 2. Candidate genes tested for association with TAHI biomarker 
                levels in urine (19 genes, 188 genetic markers) ............................................................. 15 
Table 3. Summary of study participant characteristics, exposure values,  
                and biomarker values (n = 33). Exposure mean and ranges are  
                of the geometric mean of daily exposure sums during each visit ................................. 18 
Table 4. Top ten SNP results ......................................................................................................... 19 
Table 5. Cook's distances between rs12955846 and biomarker level that 
                are greater than 0.129 (4/n, in which n=31). Covariates: Current  
                smoking status, geometric mean of HDI isocyanurate breathing- 
                zone level (paint-time and APF-adjusted), skin HDI isocyanurate  
                level, and ethnicity ......................................................................................................... 20 
Table 6. The distribution of creatinine adjusted urine TAHI concentrations 
                (µg/g creatinine) for each rs12955846 genotype .......................................................... 21 
Table 7. Linear mixed model solutions for fixed effects from added-last 
                Wald tests. The dependent variable is the natural log of the 
                 total creatinine adjusted urine TAHI level ..................................................................... 21 
Table 8. Genes associated with the top ten SNPs ........................................................................ 22 
Table 9. Description from NCBI’s Reference Sequence (RefSeq) database  
                of genes proximal to the ten most influential SNPs ....................................................... 23 
Table 10. Genes types and names for genes without a description on NCBI 
                  for genes proximal to the ten most influential SNPs on TAHI levels ............................ 24 
Table 11. Functions of genes in the associated protein networks ............................................... 26  
 ix 
LIST OF FIGURES 
 
Figure 1. Reaction between a Polyisocyanate and a polyol to form polyurethane ....................... 1 
Figure 2. (a) Chemical structures of the most heavily produced diisocyanates 
                 (adapted from Fent et al., 2008). (b) Chemical structures of common HDI 
                 oligomers (adapted from Fent et al.,2008)  .................................................................... 2 
Figure 3. Chemical structure of trisaminohexyl isocyanurate (TAHI), which 
                 is a biomarker of HDI isocyanurate exposure. m/z = 426 ............................................... 5 
Figure 4. Diagnostic residual plots from linear model of rs12955846 and 
                 creatinine adjusted urine TAHI level geometric mean .................................................. 19 
Figure 5. Distribution of allele frequencies for rs12955846 genotypes with 
                 the geometric mean values of creatinine adjusted urine TAHI  
                 concentrations; T is the minor allele (n = 31) ................................................................ 20 
Figure 6. GeneMANIA protein network interactions between genes proximal 
                 to the top ten SNPs associated with TAHI biomarker levels ......................................... 25 
  
 x 
LIST OF ABBREVIATIONS 
 
A   Adenine 
ADME   Absorption, distribution, metabolism, excretion 
APF    Assigned protection factor  
C   Cytosine  
C14ORF39   Chromosome 14 open reading frame 39 
CELF4  Cytosine-uracil-guanine triplet repeat RNA binding protein, Elav-like  
family member 4 
 
CTNNA3   α-T-catenin 
DNA     Deoxyribonucleic acid  
FDR    False discovery rate  
G   Guanine 
GM   Geometric mean 
GOLIM4   Golgi integral membrane protein 4 
GST    Glutathione-S-transferase  
GWAS   Genome-wide association study  
HDA    1,6-hexamethylene diamine  
HDI    1,6-hexamethylene diisocyanate  
HLA    Human leukocyte antigen  
IL   Interleukin 
MAF   Minor allele frequency 
MAGI1   Membrane associated guanylate kinase, WW and PDZ domain containing 
 xi 
miRNA   MicroRNA 
mRNA   Messenger RNA 
MDI   Methylene diphenyl diisocyanate 
MDL   Method detection limit 
NAT    N-acetyltransferase 
NCBI   National Center for Biotechnology Information 
OSHA   Occupational Safety and Health Administration  
PBMC    Peripheral blood mononuclear blood cells  
QC   Quality control 
RefSeq   NCBI’s reference sequence database 
RNA   Ribonucleic acid 
rs    Reference SNP  
SAS   Statistical analysis system 
SERPINI1   Serpin family I member 1 
SIX4   Sine oculis homeobox 4 
SNP    Single nucleotide polymorphism 
T   Tyrosine 
TAHI   Trisaminohexyl isocyanurate 
TDI   Toluene diisocyanate 
TMEM   Transmembrane protein 261 
ZFR   Zinc finger RNA binding protein 
  1 
CHAPTER 1: INTRODUCTION 
Diisocyanates Overview 
Diisocyanates are very reactive chemicals that are one of the most frequently reported 
causes of occupational asthma (Malo et al., 2009). Due to their reactive nitrogen-carbon-
oxygen (-N=C=O) groups, diisocyanates readily react with water and also hydroxyl, amine, and 
sulfhydryl groups on proteins (Figure 1) (ACGIH, 2015). In industry, these chemicals are reacted 
with polyols to produce polyurethane and they pose a risk for workers with high levels of 
exposure, including workers who spray foam insulation and who apply paint to automobiles 
and airplanes.  
 
 
 
 
 
FIGURE 1. Reaction between a polyisocyanate and a polyol to form polyurethane (chemical 
structure attributed to Cyfer from zh). 
 
The most common diisocyanates are methylene diphenyl diisocyanate (MDI), toluene 
diisocyanate (TDI), and 1,6-hexamethylene diisocyanate (HDI) (Figure 2a). In 2000, 4.4 million 
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tonnes of diisocyanates were manufactured globally and, in 2002, the production of 
diisocyanates was estimated to be increasing by about 5% per year (Randall et al., 2002). Within 
the automotive spray-painting industry, paint formulations tend to contain aliphatic 
diisocyanates like HDI for their greater durability and increased resistance to degradation by UV 
radiation compared to aromatic diisocyanates like MDI and TDI (Randall et al., 2002). Within 
these automobile paints are mixtures of HDI monomer and its oligomers which include 
uretdione, biuret, and isocyanurate (Figure 2b). Typically, the oligomers of HDI are present in 
greater amounts than the monomer (2.5 – 20% compared to only about 0.5%, respectively) 
(Bello, 2005; PPG 2007a; PPG 2007b). 
 
FIGURE 2. (a) Chemical structures of the most heavily produced diisocyanates (adapted from 
Fent et al., 2008). (b) Chemical structures of common HDI oligomers (adapted from 
Fent et al., 2008). 
 
b 
a 
Uretdione Biuret Isocyanurate 
1,6-Hexamethylene Diisocyanate (HDI) 
2,4-Toluene Diisocyanate (TDI) 4,4’-Methylenebisphenyl Diisocyanate (MDI) 
(a) 
(b) 
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Occupational Exposure to Diisocyanates 
Multiple factors can affect the level of inhalation and skin exposure that workers 
experience. Diisocyanate aerosols and vapors can be inhaled, deposited on the skin (Fent et al., 
2008; Fenske, 1993), or can even penetrate through protective gloves and reach the skin 
surface (Liu et al., 2000; Ceballos et al., 2014). Air temperature and relative humidity impact the 
concentration of airborne HDI in polyurethane work stations (Mirmohammadi, 2010). Other 
factors include the type of ventilation in the booths, the type of respiratory protection worn 
(e.g., half-face, full-face, or supplied-air respirator), and the presence or absence of other 
personal protective equipment, e.g., coveralls and gloves (Gaines et al., 2011; Fent et al., 2009a; 
Fent et al., 2009b). The pressure of the spray gun also affects the level and size of aerosols 
produced; conventional spray guns which use higher pressures produce smaller aerosols than 
the newer high-volume low-pressure (HVLP) spray guns (Fent et al., 2008; Fent et al., 2009b). 
Regarding skin exposure, diisocyanates are able to readily penetrate through the 
stratum corneum (Thomasen et al., 2011a). Thomasen and Nylander-French observed that the 
dose received through skin exposure to isocyanate-containing clearcoats in an occupational 
setting has a great potential to exceed established regulatory exposure limits for inhalation 
exposure (Thomasen, & Nylander-French, 2012). They also observed that HDI isocyanurate 
penetrates the skin much more quickly than the HDI monomer (Thomasen, & Nylander-French, 
2012), reporting a skin absorption time between 14 seconds and 1.7 minutes for HDI 
isocyanurate compared to 10 minutes for HDI monomer at a dose rate of 1.33 mg/cm2h. Based 
on the short-term absorption rates for the slow-drying clearcoat of 10 minutes (1.33 mg/cm2h), 
they calculated that it would take approximately 6.5 minutes to achieve a dose equivalent to 
  4 
the American Conference of Governmental Industrial Hygienists’ threshold limit value of 34 
mg/m3 for HDI monomer (Thomasen, & Nylander-French, 2012). 
 
Diisocyanate and Isocyanurate Metabolism and Biomarkers 
To monitor exposure to hazardous agents, biomarkers of exposure are commonly used 
along with the environmental exposure monitoring. A biomarker was defined by a World Health 
Organization task group as “any substance, structure, or process that can be measured in the 
body or its products and influence or predict the incidence of outcome or disease” (WHO, 2001). 
In the case of diisocyanates, protein-adducts in blood and metabolites in urine have been used 
as biomarkers of exposure. Flack et al. proposed that HDI is metabolized to 1,6-hexamethylene 
diamine (HDA) via cytochrome P450 (CYP450), glutathione-S-transferase (GST), and N-
acetyltransferase (NAT) (Flack et al., 2010). HDA is excreted in urine quickly with a half-live of 
≈2.9 h (Gaines et al., 2010). Previous studies have shown that urine HDA levels are correlated 
well with same-day measurements of HDI exposure (Gaines et al., 2010a; Gaines et al., 2010b; 
Gaines et al., 2011). For HDI isocyanurate, the metabolism of HDI isocyanurate is unknown but 
a hydrolysis product of HDI isocyanurate, trisaminohexyl isocyanurate (TAHI), is a potential 
urine biomarker of HDI isocyanurate exposure (Figure 3) (Robbins et al., 2016). 
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FIGURE 3. Chemical structure of trisaminohexyl isocyanurate (TAHI), which is a biomarker of 
HDI isocyanurate exposure. 
 
Diisocyanate Health Effects and Evidence of Sensitization 
Due to asthma being the primary health concern, much of the focus to protect workers 
from diisocyanate exposure has been to reduce inhalation exposure. In 2005, Whittaker et al. 
reported that automotive spray-painters almost always wore respirators but did not always 
wear coveralls and gloves (Whittaker et al., 2005). However, despite greatly reduced inhalation 
exposures, there is still a high incidence of sensitization resulting in diisocyanate asthma, even 
when inhalation exposures have been extremely low and/or below the limit of detection (Bello 
et al., 2007). In these cases, there was an opportunity for skin exposure in occupational 
exposure setting (Bello et al., 2007). The potential for respiratory asthma to occur following skin 
exposure is concerning. 
Since occupational asthma is characterized by airflow obstruction, airway inflammation, 
and lung hyper-responsiveness upon exposures to chemical triggers in the workplace (Lummus 
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et al., 2011; Mapp et al., 2002) a worker who develops asthma is often required to change 
his/her occupation. Estimates range from 5 – 15% of exposed workers develop diisocyanate 
asthma (Wisknewski, & Redlich, 2001). It is now known that isocyanates can cause sensitization 
and asthma not only after inhalation exposure, but also after skin exposure alone (Beck et al., 
2000; Aalto-Korte et al., 2012). The mechanism of isocyanate sensitization is poorly understood. 
However, in the cases of diisocyanate asthma, it has been reported that the histology of 
diisocyanate asthma and prototypic common environmental asthma are identical, but the 
pathologic mechanisms differ, including lower T-helper type 2 cell and lower IgE response in 
diisocyanate asthma (Cartier et al., 1989; Wisknewski, 2008). Cases have even been 
documented of patients who tested positive for skin sensitization to HDI trimers, including HDI 
isocyanurate, while testing negative for HDI monomer (Aalto-Korte et al., 2010). 
 
Changes in Gene Expression Following Diisocyanate Exposure 
Although the mechanism of sensitization is not known, changes in gene expression and 
epigenetic markers have been observed following diisocyanate exposure. Macrophages 
exposed to HDI in vitro had differences in expression levels of genes involved in detoxification, 
oxidative stress, cytokine signaling, and apoptosis (Verstraelen et al., 2008). It has also been 
found that monocytes take up HDI-conjugated albumin and experience changes in their 
morphology and gene expression, especially lysosomal genes including proteases, peptidases, 
and proton pumps that are important for antigen processing (Wisnewski et al., 2008). 
Peripheral blood mononuclear cells (PBMCs) challenged in vitro with HDI-albumin exposure also 
released more than twice as much of the inflammatory chemokine macrophage migration 
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inhibitory factor (MIF) compared to controls (Wisnewski et al., 2008). This shows that HDI 
exposure has the ability to alter gene expression levels of the innate immune system. 
 
Genetic Associations with Diisocyanate Asthma 
Genetic polymorphisms have been associated with the occurrence of diisocyanate 
asthma. Wikman et al. reported that polymorphisms in the metabolizing enzyme glutathione-S-
transferase (GST) genes GSTM1, GSTM3, GSTP1, and GSTT1 and the putative slow acetylator 
NAT1 and NAT2 genotypes were significant risk factors for the development of allergic 
responses following diisocyanate exposure to MDI, TDI, and HDI (Wikman et al., 2001). 
Diisocyanate asthma has also been associated with interleukin (IL) wild IL4RA (150V) II genotype 
and the human leukocyte antigen (HLA) class II haplotypes and alleles DQB1*0503, a 
combination of DQB1*0201/0301 (whereas DQA1*0101-DQB1*501-DR1 haplotype was found 
to be protective) (Bernstein, 2011). And single nucleotide polymorphisms (SNPs) of α-T-catenin 
(CTNNA3) gene were observed to be significantly associated with diisocyanate asthma in a 
genome-wide association study (GWAS) (Kim et al., 2009). Further investigation to genetic 
polymorphisms could help determine the mechanisms behind the development of diisocyanate 
asthma. 
 
Genetic Associations with Diisocyanate Biomarkers 
Sun observed 25 SNPs that were significantly associated with the concentrations of the 
HDI monomer biomarker (HDA) in urine and blood (Sun, 2016). These SNPs were proximal to 
genes that coded for proteins that are important for cell adhesions and xenobiotic trafficking 
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channels. She also investigated the potential of 19 candidate genes implicated to be involved in 
the diisocyanate toxicokinetics or health effects caused by diisocyanate exposures (e.g., 
occupational asthma) by searching curated scientific literature (Sun, 2016). SNPs that are within 
20,000 base pairs of the candidate genes were evaluated for potential association between 
genetic markers and urine levels of HDA. None of the 188 genetic markers proximal to the 
candidate genes were observed to be significantly associated with HDA levels in the urine or 
blood of the exposed workers (Sun, 2016). 
 
Diisocyanate Knowledge Gaps 
There are still large knowledge gaps surrounding diisocyanate exposures, absorption, 
distribution, metabolism, excretion, and associated health effects. More research is needed on 
exposure characterization, exposure and disease prevention, and the mechanisms behind 
diisocyanate sensitization (Lockey et al., 2015). GWAS and bioinformatics analysis may help to 
identify pathways that are important for absorption, distribution, metabolism, excretion 
(ADME) of diisocyanates and to identify individual susceptibility markers that are associated 
with urine and/or blood biomarkers of diisocyanate exposure. 
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CHAPTER 2: SPECIFIC AIMS 
We have previously demonstrated a clear dose-response relationship between 
occupational inhalation and skin exposure to HDI and HDA biomarker levels in urine and blood 
(Gaines et al., 2010; Gaines et al., 2011; Flack et al., 2010; Flack et al., 2011). In addition, we 
observed that HDA levels in urine can be impacted by individual differences in genetic variation 
(Sun, 2016). The purpose of this study was to investigate if genetic polymorphic markers affect 
urine HDI isocyanurate biomarker levels of TAHI in workers exposed to HDI isocyanurate. 
Specifically, our aims were to: 
(1) Identify genetic polymorphic markers that are significantly associated with levels of TAHI 
biomarker in the urine of automobile spray-painters exposed to HDI isocyanurate. 
(2) Investigate the potential biological plausibility of the genes associated with the most 
influential genetic polymorphic markers. 
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CHAPTER 3: METHODS 
Study Participants 
The characteristics of the study population have been previously described in Flack et al. 
2010b and Gaines et al. 2010a. In summary, 47 automotive repair spray-painters from Raleigh-
Durham North Carolina (NC) and Puget Sound Washington (WA) were recruited for the study on 
diisocyanate exposure. Of the 47 workers who participated, 15 painters were from NC and 32 
were from WA. A complete genetic and exposure data set was available for 33 of the 47 
workers. The participants with complete data were an average age of 35 ± 9.3 years old (range 
of 21 to 59 years old), were predominantly of Caucasian decent (23 of the 33), had been in a 
spray-painting job for an average of 13.1 ± 10.4 years (range of 0.5 – 35 years), and all were 
males. The participants who were not Caucasian identified themselves as Hispanic (3 workers), 
mixed race (2 workers), Native American (1 worker), Asian (1 workers), or African American (1 
worker). The study was approved by the University of North Carolina at Chapel Hill Office of 
Human Research Ethics Institutional Review Board and by the Washington State Department of 
Social and Health Services Institutional Review Board 
 
Assessment of Exposure and Biomarker Levels 
Methods used for measuring and modeling skin and inhalation HDI monomer and 
oligomer exposures are described in previous studies (Gaines et al., 2010a; Fent et al., 2008; 
Fent et al., 2009a; Fent et al., 2009b; Flack et al., 2011). Briefly, 47 consenting workers were.
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visited up to three times during the span of a year, with each visit spaced at least one month 
apart. Of the 33 workers with full data evaluated in this study, a complete exposure and 
biomarker data set from three visits was available for 22 workers and complete data from two 
visits was available for 11 workers. Most of the painting tasks that were monitored were 
clearcoat applications (92%) because clearcoat formulations have higher levels of HDI monomer 
and oligomers compared to surface coatings and primers (Woskie et al., 2004). 
Breathing-zone concentrations of HDI monomer and HDI isocyanurate were monitored 
during each paint task using two-stage filter cassettes (37-mm polystyrene cassette; SKC Inc., 
Eighty Four, PA) connected to a high-flow air pump operating at 1 L/min. The pre-filter had 
untreated polytetrafluorethylene with 5 µm pores (PTFE; Millipore Corp., Billerica, MA) 
designed to capture diisocyanate aerosols, followed by a glass-fiber filter with 1 µm pores (GFF; 
SKC Inc.) which was treated with a derivatizing agent [1-(2-methoxyphenyl)piperazine (MPP) in 
toluene] designed to capture diisocyanate vapors. Right after the completion of each painting 
task, the filters from the cassettes were processed in a derivatizing solution consisting of 2 
grams of MPP dissolved in 11 grams of 30% volume per volume of N,N-dimethylformamide in 
acetonitrile. The samples were then quantified using liquid chromatography-mass spectrometry 
(LC-MS) with selective ion monitoring described in Fent et al. (2008). 
Inhalation exposure to isocyanurate was estimated for each painting task by multiplying 
the measured air concentration by the number of minutes painting during each task and then 
dividing this calculated breathing-zone concentration by the assigned protection factor (APF) 
for the respirator worn by the spray-painter. The APF was based off of guidelines by the 
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Occupational Safety and Health Administration (OSHA, 2006) and varied depending on the type 
of respirator the worker was wearing during the spray-painting operation (Table 1). 
TABLE 1. Assigned protected factors for type of respiratory protection worn by workers. 
Respiratory Protection Worn Assigned Protection Factor (APF) 
None 1 
Air purifying half-face 10 
Air purifying full-face 50 
Powered air-purifying (PAPR) full-face or hood 1,000 
Supplied air full-face or hood 1,000 
 
Skin exposure was measured immediately after each paint task using a tape-strip 
method (Fent et al., 2008). Three sequential tape strips (4 cm × 2.5 cm, Cover-Roll® adhesive 
tape Beiersdorf AG, Hamburg, Germany) were collected on the dorsal side of each hand and on 
the dorsal and volar side of each lower arm, as described previously (Fent et al., 2009). The tape 
strips were then placed in a glass vial containing the same derivatizing solution as for the air 
sampling filters and analyzed using LC-MS (Fent et al., 2009). 
TAHI levels in urine were quantified using ultraperformance liquid chromatography 
coupled with electrospray ionization tandem mass spectrometry (UPLC–ESI-MS/MS) (Robbins et 
al., 2016). 
 
Genotyping and Quality Control Procedures 
Whole blood samples were collected in EDTA anticoagulant tubes during one visit and 
the peripheral blood mononuclear cells (PBMCs) were separated from centrifuged whole blood 
using FicollTM separation. Next, QiaAmp Blood mini kits (Qiagen, Germantown, MD) were used 
to pellet deoxyribonucleic acid (DNA) from the PBMCs and the DNA was stored at –20oC in 
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elution buffer until analysis. For genetic marker analysis, the DNA was thawed, quantified using 
a NanoDrop spectrophotometer (Thermo Fisher Scientific, Waltham, MA), and diluted to 50 
ng/µL with 10 mM Tris, pH 7.4. For ten of the samples, Qiagen Repli-g gemonimc amplification 
kit was used to increase DNA levels. The DNA samples for all workers were digested using 
restriction enzymes, purified, ligated to Affymetrix SNP 6.0 Core Reagent Kit adaptors, and 
amplified with generic primers for the adaptor sequence using polymerase chain reaction (PCR). 
The DNA PCR fragments were then hybridized to the Affymetrix Genome-wide Human SNP 
Array 6.0 (Affymetrix, Santa Clara, CA), which has about 1.8 million probes featuring more the 
906,600 SNPs and 946,000 invariate probes for assessing copy number variants (CNVs). DNA 
was successfully processed for the 33 workers. 
PLINK (Purcell et al., 2007), an open source genome association analysis toolset, was 
used to clean the genotyping data. For quality control (QC), only individuals with <10% missing 
data were included and only autosome markers that did not fail the Hardy-Weinberg departure 
with p-value <0.001, that were successfully genotyped at a rate >90%, and had a minor allele 
frequency (MAF) >0.1 were included in the cleaned data set. Markers from the X chromosome 
were not included in the analysis because of QC issues with those markers. 
 
Genome-Wide Association Study (GWAS) 
Analysis of genotyping data was performed using PLINK v1.9 (Purcell et al. 2007). The 
program is designed for genetic analyses, in which genotypes were assigned numeric codes 
based off of the minor allele (e.g., AA = 0, AT = 1, TT = 2, if T is the minor allele). Genetic marker 
associations with TAHI biomarker levels were investigated using multiple linear regression 
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analysis that incorporated the genotyping and covariate data. Genetic markers were considered 
to be statistically significant at a false discovery rate (FDR) q < 0.20, as recommended by Efron 
(2007). FDR is a statistical test developed by Benjamini and Hochberg that aims to reduce the 
type I error rate (false positives) when making multiple comparisons (Benjamini, & Hochberg, 
1995). The FDR is the expected proportion of false positives and the method is designed to 
satisfy the equation (Genovese, 2004): 
FDR ≡ E( 
Number of false positives
Total number of positives
) ≤ α. 
This study paralleled our previous study on HDI monomer biomarker levels (Sun, 2016) 
in that the analogous covariates were incorporated in the analyses: HDI isocyanurate inhalation 
and skin exposure estimates, ethnicity, and current smoking status. Because PLINK is unable to 
accommodate multiple measurements for a single variable for each subject, estimates of 
overall exposure were calculated for inhalation and skin exposures for each spray-painter. For 
HDI isocyanurate inhalation estimates, breathing-zone concentrations of HDI isocyanurate were 
multiplied by the number of minutes painted during each task and divided by APF, summed for 
all tasks during each visit to determine the HDI isocyanurate inhalation exposure for that day, 
and then the geometric mean was calculated across all of the visits for that worker. For HDI 
isocyanurate skin exposure, HDI isocyanurate level measured in the skin tape-strips were 
summed for each visit and then the geometric mean was calculated from all of the visits for 
each worker. Due to the small sample size, ethnicity was coded as 0 for non-Hispanic 
Caucasians and 1 for other ethnicity. Current smoking status was coded as 0 for a non-smoker 
and 1 for a current smoker as self-reported by the workers in a questionnaire. 
  15 
After genetic associations were determined in PLINK, SAS (which stands for Statistical 
Analysis System) was used to calculate Cook’s distance (D) using PROC GLM (which uses the 
least squares method to fit general linear models).and also to a generate box-and-whisker plot 
of the distribution of urine TAHI level by allele using PROC SGPLOT (which is a procedure for 
plotting statistical graphics). 
 
Candidate-Gene Analysis 
The candidate genes identified from a curated scientific literature and previously used 
to assess HDI monomer exposure (Sun, 2016) were used to evaluate potential association 
between HDI isocyanurate exposure and markers that are proximal to those candidate genes 
(Table 2). PLINK was used to analyze 188 genetic markers within 20 kilobase pairs of 19 
candidate genes that are implicated in the toxicokinetics or health effects of diisocyanates in a 
search of the curated literature (Broberg et al., 2008; Hoffjan et al., 2003; Liu and Wisnewski 
2003; Maestrelli et al., 2009; Mapp et al., 2002; Ober and Hoffjan 2006) performed by Sun 
(2016). 
TABLE 2. Candidate genes tested for association with TAHI biomarker levels in urine (19 genes, 
188 genetic markers). 
Gene 
Number of 
Markers 
Gene 
Number of 
Markers 
Gene 
Number of 
Markers 
ADRB2 29 GSTP1 7 IL13 17 
CCL5 7 GSTT1 19 LTA 9 
CD14 5 HLA-DPB1 11 NAT1 29 
CD4 7 HLA-DQA1 38 NAT2 22 
CYP1A1 3 HLA-DQB1 35 SERPINA1 8 
GSTM1 11 HLA-DRB1 34 TNF 8 
GSTM3 21         
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Linear Mixed Effects Exposure Model 
Linear mixed-effects model using PROC MIXED with compound symmetry in SAS was 
used to assess the contribution of the significant SNPs identified in the GWAS to TAHI 
biomarker levels. The model included natural log-transformed data from every visit for each 
worker because SAS is able to process multiple data points for each variable for every subject 
(e.g., for biomarker and exposure values across several visits instead of using the geometric 
mean). All exposure and biomarker values were natural log-transformed to satisfy normality 
assumption for statistical analyses. Association of the significant genetic marker(s) with natural 
log-transformed urine creatinine adjusted TAHI levels was determined by fitting the linear 
effects mixed model for the ith worker at the jth visit (𝑌𝑖𝑗). The model accounts for random 
effects (𝛼𝑖) over multiple sampling visits. Natural log (ln) of Xijp represents the natural log of the 
pth HDI isocyanurate exposure level for the ith worker at the jth visit (i.e., HDI isocyanurate 
inhalation or skin exposure), Cijq represents the qth covariate value (i.e., personal and workplace 
factors; e.g., ethnicity, current smoker status) for the ith worker on their jth visit, Sig represents 
the gth genetic marker for the ith worker, and βp, γq, and λg represent the corresponding 
regression coefficients while 𝛼𝑖 and 𝜀𝑖𝑗, an independent error term, both have mean 0 and fixed 
variance. The model was: 
ln(𝑌𝑖𝑗) = 𝛽0 + ∑p=1
p
𝛽𝑝 ln(𝑋𝑖𝑗𝑝) + ∑q=1
Q  𝛾𝑞𝐶𝑖𝑗𝑞 + ∑g=1
G  λgS𝑖g + 𝛼𝑖 + 𝜀𝑖𝑗 
SAS fits the data to the model using a maximum likelihood-based method and generates 
parameter estimates and Wald-test statistics for the fixed effects based on added-last model 
comparisons. 
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Bioinformatics Analysis 
First, the proprietary Affymetrix coding for SNP alleles were converted to reference 
sequence (rs) cluster IDs (identification) numbers using the January 2017 annotation file from 
Affymetrix for the Genome Wide Human SNP Array 6.0 (available under support files for catalog 
item 901153 on www.thermofisher.com). The most influential SNPs were searched in the single 
nucleotide polymorphism database (dbSNP) from the National Center for Biotechnology 
Information (NCBI) database using their rs IDs to identify nearby coding genes and potential 
regulatory elements. This set of genes was then input into GeneMANIA to identify and explore 
potential network interactions based on the ten most influential SNPs identified. GeneMANIA 
uses a label propagation algorithm to predict direct and indirect network interactions based off 
of validated protein-protein and protein-DNA interactions (Zuberi et al., 2013). For this study, 
GeneMANIA was used to search for co-expression, co-localization, genetic interactions, 
pathways, physical interactions, predicted networks, shared protein domains, consolidated-
pathways, micro ribonucleic acid (miRNA) predications, and transcriptional factor targets, in 
which the gene ontology based weighting was based on molecular function. Literature searches 
were also conducted for each gene and regulatory element separately in the NCBI databases 
Entrez gene, dbSNP, and PubMed to learn what is known about their functions. 
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CHAPTER 4: RESULTS 
Exposure and Biomarker Levels 
Each worker performed an average of 2.4 painting tasks per visit, totaling an average of 
21 minutes per visit, which resulted in a wide range of HDI isocyanurate exposure levels among 
the study participants (Table 3). For urine TAHI measurements, the method detection limit 
(MDL) of was 0.04 µg/L; TAHI was not detected in 33% of the workers during any of their visits. 
TABLE 3. Summary of study participant characteristics and the geometric means of daily 
exposure and biomarker levels (n = 33). 
Characteristic Mean ± STD Range 
Number of tasks per worker per sampling visit  2.4 ± 1.3 0 – 5 
Time painting during the day (minutes) 21.4 ± 21.0 2 – 98 
HDI isocyanurate breathing-zone concentration adjusted for 
respirator APF and paint time (µg/m3) 3,654 ± 7,646 1.740 – 50,748 
HDI isocyanurate skin concentration (µg/mm3) 3,654 ± 8,646 166.8 – 841,673 
Urine TAHI concentration normalized with creatinine (µg/g) 0.35 ± 0.83 ≤MDL* – 3.47 
APF = assigned protection factor; STD = standard deviation; MDL = method detection limit; *Samples 
below the MDL were assigned a value of MDL/(100 * √2) to satisfy normality assumption for statistical 
analyses 
  
Genome-wide Analysis 
The genotyping rate of the worker’s PBMCs was 98.5% and 533,673 SNPs passed the 
quality control. Analysis of biomarker levels with ethnicity, current smoking status, and 
inhalation and skin HDI isocyanurate levels as covariates using a linear regression model in 
PLINK resulted in one SNP that was significantly associated with creatinine adjusted urine TAHI 
levels; rs12955846 (FDR = 0.1661) (Table 4). 
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Next, diagnostics were further assessed using the same covariates and this statistically 
significant SNP (rs12955846, coded numerically as CC = 0, CT = 1, or TT = 2) using PROC GLM. 
The distribution of the biomarker data revealed that the data appears to follow Gaussian 
distribution and that the least-squares assumptions are mostly met, except for at the tails 
(Figure 4). Cook’s distances were also calculated for the genetic association between 
rs12955846 and creatinine adjusted TAHI levels (Table 5). A Cook’s distance greater than 4/n 
indicates that the data point has high leverage on the model, and may be skewing the results. 
TABLE 4. The top ten influential single nucleotide polymorphism (SNP) markers associated with 
the TAHI urine biomarker level. 
SNP P-value Bonferonni Correction False Discovery Rate Chromosome 
rs12955846 3.11E-07 0.1661 0.1661* 18 
rs2963980 1.50E-06 0.7976 0.3347 5 
rs7643651 2.28E-06 1 0.3347 3 
rs1025090 2.87E-06 1 0.3347 12 
rs7241839 3.37E-06 1 0.3347 18 
rs17379780 3.76E-06 1 0.3347 3 
rs4901995 4.49E-06 1 0.3420 14 
rs4322498 5.61E-06 1 0.3493 12 
rs17048163 5.89E-06 1 0.3493 4 
rs10124811 7.83E-06 1 0.4178 9 
* Indicates statistical significance for FDR q < 0.2 
 
FIGURE 4. Diagnostic residual plots from linear model of rs12955846 and the geometric means 
of creatinine adjusted urine TAHI levels. 
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TABLE 5. Cook's distances from the genetic association between rs12955846 and the 
geometric means (GM) of creatinine adjusted urine TAHI levels that are greater than 
4/n (0.129, in which n = 31). Covariates: Current smoking status, ethnicity, and GM of 
the paint-time and APF-adjusted HDI isocyanurate breathing-zone and skin levels. 
Obs 
Cook's 
Distance 
GM of Urine 
TAHI Level 
GM of Inhalation HDI 
Isocyanurate Level 
GM of Skin HDI 
Isocyanurate Level 
1 3.75 9.09E-04 4,469 39,309 
2 2.88 3.47 10,777 324,972 
3 2.06 1.45 105,857 1,002,645 
 
To illustrate the relationship between rs12955846 genotype and the TAHI biomarker 
level, a box-and-whisker plot was generated in SAS (Figure 5). The bottom of the box is the 25th 
percentile, the middle line in the box in the 50th percentile, the top of the box is the 75th 
percentile, and the whiskers are set at 1.5 times the interquartile range. Any outliers outside of 
that are plotted as individual points. The geometric means of the TAHI biomarker levels for all 
workers with each genotype are summarized in Table 6. 
FIGURE 5. Distribution of allele frequencies for rs12955846 genotypes with the geometric 
mean values of creatinine adjusted urine TAHI concentrations; T is the minor allele 
(n = 31). 
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TABLE 6. The distribution of the geometric mean values of creatinine adjusted urine TAHI 
concentrations (µg/g creatinine) for each rs12955846 genotype. 
rs12955846 n Geometric Mean Standard Deviation Minimum Maximum 
CC 27 7.05E-02 1.78E-01 3.16E-04 8.47E-01 
TC 3 1.64 1.74 9.09E-04 3.47 
TT 1 2.95 N/A 2.95 2.95 
 
A linear mixed model was used to estimate the contribution of the significant SNP and 
the inhalation and skin HDI isocyanurate level to the measured urine TAHI levels. The model 
had an Akaike information criterion (AIC) of 428.2. In this model, HDI isocyanurate skin 
exposure and rs12955846 genotype were significant predictors of urine TAHI levels (Table 7). 
TABLE 7. Linear mixed model solutions for fixed effects from added-last Wald tests. The 
dependent variable is the natural log-transformed total creatinine adjusted urine 
TAHI level. 
Effect Estimate 
Standard 
Error 
p-value 
Intercept -3.25 3.06 0.297 
Natural log of APF and paint-time adjusted breathing-zone 
concentration 
0.214 0.197 0.284 
Natural log of skin exposure 0.258 0.127 0.047* 
rs12955846, CC -5.95 2.59 0.029* 
rs12955846, TC -3.37 2.95 0.262 
rs12955846, TT 0 . . 
* Significant at p < 0.05. 
 
Candidate Gene Analysis 
None of the candidate genes found in published literature to be involved in the 
diisocyanate toxicokinetics or health effects caused by diisocyanates were significantly 
associated with TAHI levels in urine. 
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Bioinformatics 
The most significant SNP (with FDR < 0.20), rs12955846, is intergenic. To one side is the 
gene CELF4, and on the other side is the gene MIR924HG. CELF4 is highly expressed in the brain 
(Fagerberg et al., 2014) and is part of a gene family that regulates pre-messenger RNA (pre-
mRNA) alternative splicing, along with potentially having roles in mRNA editing and translation 
(RefSeq, 2008). MIR924HG is highly expressed in the testes and is a non-coding RNA. Other 
tissues that express MIR924HG include the skin, esophagus, small intestine, colon, fat, and 
duodenum (Fagerberg et al., 2014). 
TABLE 8. Genes associated with the top ten single nucleotide polymorphism (SNP) markers. 
SNP FDR CHR Position Alleles MA MAF 
Associated Gene and/or 
Regulatory Element 
rs12955846 0.1661 18 37890780 C/T T 0.1094 Between CELF4 and MIR924HG 
rs2963980 0.3347 5 32408624 A/C A 0.0889 ZFR (intron) 
rs7643651 0.3347 3 167890699 A/T A 0.1703 Between SERPINI1 and GOLIM4 
rs1025090 0.3347 12 45179837 T/G G 0.1278 PLEKHA8P1 (intron) 
rs7241839 0.3347 18 37977863 C/T T 0.1178 Between CELF4 and MIR924HG 
rs17379780 0.3347 3 65846134 A/G A 0.1446 MAGI1 (intron) 
rs4901995 0.3420 14 60623911 C/G C 0.1450 
LOC105378189, between 
C14ORF39 and SIX4 
rs4322498 0.3493 12 34193496 A/G G 0.2556 
Between TUBB8P4 and 
RNA5SP357 pseudogenes 
rs17048163 0.3493 4 135764238 A/G G 0.2320 
Between TARS2P1 pseudogene 
and LINC00613 
rs10124811 0.4178 9 7619582 C/T T 0.2432 
Between PPIAP33 pseudogene 
and TMEM261 
BONF = Bonferonni correction; FDR = false discovery rate; CHR = chromosome; MA = minor allele; MAF = 
minor allele frequency 
 
All associated genes and regulatory elements proximal to the top ten SNPs are listed in 
Table 8, and their functions and gene types are listed in Tables 9 and 10. The nearby protein 
coding genes and potential regulatory elements with network data were assessed in 
GeneMANIA. The genes that were input into GeneMANIA to identify and explore potential 
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network interactions were: C14ORF39, CELF4, GOLIM4, MAGI1, SERPINI1, SIX4, TMEM261, and 
ZFR (Figure 6). Only C14ORF39 did not have any network connections to the other genes (but 
very little is known about C14ORF39). In summary, GOLIM4, MAGI1, SERPINI1, and ZFR are co-
expressed; SERPINI1 and SIX4 share two transcriptional factor targets; MAGI1 and SIX4 share 
two predicted miRNA targets; and there are genetic interactions between CELF4, MAGI1, SIX4, 
TMEM261, and ZFR. 
TABLE 9. Description from NCBI’s Reference Sequence (RefSeq) database of genes proximal to 
the ten most influential SNPs. 
Gene 
Gene 
Type 
Official Name Gene Ontology Description 
CELF4 
Protein 
coding 
CUGBP, Elav-
like family 
member 4 
“Members of this protein family regulate pre-mRNA alternative splicing 
and may also be involved in mRNA editing, and translation.” [provided by 
RefSeq, Jul 2008]. 
GOLIM4 
Protein 
coding 
Golgi integral 
membrane 
protein 4 
“The Golgi complex plays a key role in the sorting and modification of 
proteins exported from the endoplasmic reticulum. The protein encoded by 
this gene is a type II Golgi-resident protein. It may process proteins 
synthesized in the rough endoplasmic reticulum and assist in the transport 
of protein cargo through the Golgi apparatus.” [provided by RefSeq, Jul 
2008] 
MAGI1 
Protein 
coding 
Membrane 
associated 
guanylate 
kinase, WW 
and PDZ 
domain 
containing 1  
“The protein encoded by this gene is a member of the membrane-
associated guanylate kinase homologue (MAGUK) family. MAGUK proteins 
participate in the assembly of multiprotein complexes on the inner surface 
of the plasma membrane at regions of cell-cell contact. The product of this 
gene may play a role as scaffolding protein at cell-cell junctions.” [provided 
by RefSeq, Jul 2008] 
SERPINI1 
Protein 
coding 
Serpin family 
I member 1  
“This gene encodes a member of the serpin superfamily of serine 
proteinase inhibitors. The protein is primarily secreted by axons in the 
brain, and preferentially reacts with and inhibits tissue-type plasminogen 
activator. It is thought to play a role in the regulation of axonal growth and 
the development of synaptic plasticity.” [provided by RefSeq, Jul 2008] 
SIX4 
Protein 
coding 
SIX 
homeobox 4 
“This gene encodes a member of the homeobox family, subfamily SIX. The 
drosophila homolog is a nuclear homeoprotein required for eye 
development. Studies in mouse show that this gene product functions as a 
transcription factor, and may have a role in the differentiation or 
maturation of neuronal cells.” [provided by RefSeq, May 2010] 
ZFR 
Protein 
coding 
Zinc finger 
RNA binding 
protein  
“This gene encodes an RNA-binding protein characterized by its DZF 
(domain associated with zinc fingers) domain. The encoded protein may 
play a role in the nucleocytoplasmic shuttling of another RNA-binding 
protein, Staufen homolog 2, in neurons. Expression of this gene is 
regulated through alternative polyadenylation that mediates differential 
microRNA targeting.” [provided by RefSeq, Sep 2016] 
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TABLE 10. Genes types and names for genes without a description on NCBI Entrez Gene for 
genes proximal to the ten most influential SNPs on TAHI levels. 
Gene Gene Type Official full name 
C14ORF39 Protein coding chromosome 14 open reading frame 39 
LOC105378189 Protein coding LOC105378189 
MIR924HG 
non-coding (nc) 
RNA 
MIR924 host gene 
PLEKHA8P1 Pseudo 
pleckstrin homology domain containing A8 
pseudogene 1 
PPIAP33 Pseudo peptidylprolyl isomerase A pseudogene 33 
TARS2P1 Pseudo 
threonyl-tRNA synthetase 2, mitochondrial (putative) 
pseudogene 1 
TMEM261 Protein coding transmembrane protein 261 
TUBB8P4 Pseudo tubulin beta 8 class VIII pseudogene 4 
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FIGURE 6. GeneMANIA predicted protein network interactions between predicted genes and 
products of genes near the top ten SNPs associated with TAHI biomarker levels. 
 
The functions of the associated genes and potential regulatory elements in the 
GeneMANIA output are summarized in Table 11. The functions mainly consist of kinase activity, 
ion channel activity, and cell-cell junctions. 
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TABLE 11. Functions of genes in the associated genes and potential regulatory element 
networks predicted by GeneMANIA. 
Function  FDR Function  FDR 
query genes n/a apical junction complex 6.30E-03 
guanylate kinase activity 2.11E-11 
calcium ion transmembrane 
transporter activity 
6.30E-03 
nucleotide kinase activity 6.17E-10 
voltage-gated calcium channel 
complex 
8.70E-03 
phosphotransferase activity, 
phosphate group as acceptor 
1.24E-08 cell-cell junction 1.03E-02 
nucleobase-containing compound 
kinase activity 
3.98E-08 
divalent inorganic cation 
transmembrane transporter 
activity 
1.04E-02 
nucleotide phosphorylation 3.39E-07 
voltage-gated cation channel 
activity 
2.36E-02 
voltage-gated calcium channel 
activity 
1.66E-04 
voltage-gated ion channel 
activity 
2.75E-02 
tight junction 3.67E-03 voltage-gated channel activity 2.75E-02 
occluding junction 3.67E-03 calcium channel complex 3.01E-02 
calcium channel activity 3.99E-03 protein complex scaffold 3.53E-02 
FDR = false discovery rate 
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CHAPTER 5: DISCUSSION 
GWAS and Linear Mixed Effects Model 
In this study, I investigated if genetic variability can be associated with urine biomarker 
trisaminohexyl isocyanurate (TAHI) levels in workers exposed to HDI isocyanurate, an oligomer 
of HDI. Candidate-gene analysis of genes linked to diisocyanate sensitization and asthma did 
not show any associations with TAHI biomarker concentrations. This was expected since 
candidate-gene analysis is a more limited method than GWAS, and also because the biomarker 
levels of HDA from HDI monomer exposure were not associated with candidate genes identified 
by searching the literature either as we have previously reported (Sun, 2016).  
GWAS revealed one SNP, rs12955846, that was significantly associated with the urine 
TAHI biomarker level and explained 70% of the variance in the linear mixed effects model. The 
four covariates included in the model were ethnicity, current smoking status, and inhalation 
and skin exposure to HDI isocyanurate. In comparison to the study associating HDA biomarker 
levels with genetic markers following exposure to HDI monomer (Sun, 2016), the TAHI 
biomarker level associations were not as strong for HDI isocyanurate. Because so little is known 
about the ADME of HDI isocyanurate, the implications of this are unclear. These results indicate 
that more research is warranted to understand the implications of diisocyanate oligomer 
exposures and the effect of individual susceptibility factors that may affect biomarker levels of 
diisocyanate exposures.  
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Bioinformatics 
The ten most influential SNPs observed in GWAS were all located within introns or were 
intergenic (between genes and/or pseudogenes). Even though none of the SNPs were within 
known exons of genes that code for proteins, they still may be important modifiers of genome 
function. SNPs within introns can influence enhancer activity (Schwartz et al., 2017) and can 
reduce mRNA (and by extension, protein) expression by altering RNA splicing (Schwartz et al., 
2017; Wang et al., 2016). Intronic SNPs have even been found to be able to cause novel splice 
variants (Wang et al., 2014). Additionally, intergenic SNPs may play important roles. Intergenic 
SNPs have been shown to influence gene expression by affecting transcription factor binding 
for nearby genes (Antontseva et al., 2015; Flora et al., 2013; Spasovski et al., 2013) and by 
affecting enhancer activity (Schierding et al., 2016). Furthermore, characterization of intergenic 
regions is constantly evolving as definitions of what constitutes a gene changes (ENCODE, 
2012), so another possibility is that the SNPs are in a region of DNA whose function is still 
unknown and/or has not been characterized, which may change over time.  
Another type of regulatory element that was proximal to the most influential SNPs were 
pseudogenes. Initially it was thought that pseudogenes have no functional purpose, because 
pseudogenes are nonfunctional homologs of genes that can no longer code proteins due to 
mutation, retrotransposition, or erroneous duplication. But even though pseudogenes can no 
longer code proteins, hundreds of pseudogenes have been found to be transcribed as RNA in 
both the sense and sometimes antisense direction (Groen et al., 2014). Some of these 
pseudogene RNA transcripts can then influence the expression of other genes that do code for 
proteins (Pink et al., 2013; Roberts et al., 2013; Li et al., 2013). Some pseudogenes participate in 
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the formation of small interfering RNA (siRNA) that regulate gene expression via RNA-
interference (Hui et al., 2013). Additionally, pseudogenes may have microRNA (miRNA) 
“sponging” functions in which they compete with the parent gene for miRNA binding (Grander 
et al., 2016; Hui et al., 2013). Therefore, despite not much being known about the particular 
pseudogenes listed in our analysis, they may have important roles in regulating genes that are 
important for HDI isocyanurate ADME. In light of the newly discovered functions of 
pseudogenes, further research into these pseudogenes may be warranted, although it is 
notable that the proximal SNPs did not reach statistical significance. 
The above research demonstrates the biological potential that the expression of genes 
and/or pseudogenes can be affected by intronic and intergenic SNPs. For genes that code 
protein this altered regulation due to the SNP could directly impact the proteome, and for 
pseudogenes this could indirectly impact protein expression levels (since pseudogenes also act 
as regulatory elements). Thus, the genes proximal to the ten most influential SNPs were 
examined. The proximal genes include protein-coding genes and also regulatory genes including 
non-coding RNA genes and/or pseudogenes. These gene ontologies are associated with mRNA 
splicing, RNA binding, cell-cell junctions, protein complex scaffolding, tight junctions, voltage-
gated channel activity, guanylate kinase activity, and phosphotransferase activity. These 
regulatory functions may or may not play a role in the metabolism of HDI isocyanurate, but 
they could feasibly affect the transport or mass movement of HDI isocyanurate inter- and intra-
cellularly.  
More specifically, one of the proteins coded by a gene proximal to the top SNP, CELF4, is 
important for neurological function and targets many mRNA, binding with high specificity for 
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mRNA genes to at least 15-20% of the transcriptome (Wagnon et al., 2012). Additionally, it is 
notable that one of the other genes, SERPINI1, is part of the same gene superfamily as one of 
the candidate genes, SERPINA1. This superfamily is known to have roles in inflammation, 
immune function, and protein aggregation (Heit et al., 2013). Specifically, SERPINI1 inhibits 
plasminogen activators (PLAT and PLAU) and plasmin, and SERPINA1 inhibits neutrophil 
elastase (Heit et al., 2013). 
In comparison to a parallel study in our laboratory, the SNPs and proximal genes that 
were associated with HDI isocyanurate biomarker levels of TAHI were different from those 
associated with the HDI monomer biomarker, HDA, for the same study population. However, 
the functions of the associated genes are similar; for both the HDI monomer and HDI 
isocyanurate, the proteins coded for by the genes proximal to the most influential SNPs are part 
of networks involved in regulating cell junctions and xenobiotic ion channels (Sun, 2016). 
Research on the metabolism and transport pathway of HDI and HDI isocyanurate is required in 
order to confirm the significance of these predicted networks and pathways. 
Further investigation of which genes are affected by these SNPs could be performed 
using a method developed by Macintyre et al (Macintyre et al., 2014). I have discussed genes 
that are proximal to the SNPs that are intergenic, but the method by Macintyre et al uses the 
three-dimensional spatial relationships of chromatin to be able to predict interactions between 
intergenic disease-associated SNPs with gene targets in other regions of the chromosome(s) 
other than just those that are sequentially proximal to the SNPs. Performing this type of 
analysis on the SNPs could provide additional genetic and protein networks to investigate. 
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Limitations 
One limitation in this study is the potential underestimation of the inhalation and skin 
exposure levels. All spray-painters used some form of respiratory protection. In order to 
incorporate that into our exposure assessment models, the measured breathing-zone 
concentrations were adjusted for the type of respirator worn, because different types of 
respirators provide different levels of protection (such as those using filters versus supplied air). 
However, true inhalation exposure may differ from these adjusted values. Skin exposure 
estimates are impeded too because HDI isocyanurate penetrates through the skin very rapidly 
(Thomasen, & Nylander-French, 2012), but tape-strip sampling provides a point estimate of the 
skin exposure through only the first 5 µm of the stratum corneum (Nylander-French, 2000). 
Thus, any amount that has already penetrated through the first 5-10 cell layers of the stratum 
corneum will not be accounted for in the measured levels of skin exposure. Additionally, 
because the metabolism and elimination pathways for HDI isocyanurate are not known, urine 
samples for biomarker quantitation were collected throughout the work-day only based off of 
the short half-life for HDA. Thus, determination of the half-life for HDI isocyanurate and making 
appropriate adjustments in the time of sample collections are needed to improve exposure and 
risk assessment for HDI isocyanurate. 
Another challenge for analysis was the wide range of biomarker values, including many 
samples that were below the MDL. This introduced a heavily left-censored data set. In order to 
satisfy the normality assumption for statistical analyses, the non-detected values were assigned 
a value that was based on the MDL of the analytical method. However, this methodology did 
not fully satisfy statistical assumptions for normality in the linear mixed effects model. In future 
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studies, minimizing left-censored data could be achieved by improving the analytical 
methodology for TAHI quantitation and by increasing the study participant sample size. In 
addition, imputation methodology can be incorporated into the model analyses. To our 
knowledge, imputations of exposure data has not been applied previously in GWAS studies and, 
thus, this methodology has to be further evaluated. 
Furthermore, a limitation of the small sample size with minor allele frequencies around 
10% for GWAS and utilization of the linear mixed effects model is that there may only be a few 
individuals who are homozygous for the minor alleles of the SNPs that were genotyped, which 
could be further impacted by genotyping of a particular SNP for a worker(s) failing QC. For this 
study, only one worker was successfully genotyped as homozygous for the rs12955846 minor 
allele, resulting in that worker’s data having a high influence in GWAS and the linear mixed 
effects model (and only three workers were successfully genotyped as heterozygous for the 
minor allele). Notably though, there were two individuals who were not successfully genotyped 
for rs12955846, so (if possible) re-genotyping those two workers may improve the accuracy of 
the model. Ultimately, SNP associations with biomarker levels could be strengthened using a 
larger sample of exposed individuals that includes more individuals who are homo- and 
heterozygous for the minor allele at that locus. 
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CHAPTER 6: CONCLUSIONS 
Overall, we have demonstrated that genetic polymorphic markers are associated with 
biomarker levels following exposure to HDI isocyanurate. Larger studies need to be conducted 
to further investigate the association between rs12955846 and HDI isocyanurate exposure, and 
bioinformatics studies are needed to investigate the biological plausibility of this association. 
More information on HDI isocyanurate metabolism, excretion, and half-life would aid the 
conduction of such future studies. In conclusion, more research is warranted to understand 
how diisocyanate oligomer biomarker levels are impacted by genetic polymorphisms and what 
the biological implications are for these inter-individual differences. 
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APPENDIX A: PLINK CODE 
Genome-wide Analysis 
Raw data from Affymetrix software was previously output to PLINK format (PED, MAP files) 
which were then converted to binary BED (and BIM and FAM) files for faster processing in 
PLINK.  
 
plink --file output3_ALL_standard_plink_24Sep2014 --make-bed --out 
output3_ALL_standard_plink_24Sep2014 
 
plink --bfile output3_ALL_standard_plink_24Sep2014 --hwe 0.001 --mind 0.1 --maf 0.1 --geno 
0.1  --autosome --make-bed --out 56_final_10p_12Apr2015 
 
The covariate file used was Covariates_03-17-17.txt and the phenotype file was 
Biomarker_LOD10+100gms_-4visits_-U65_03-07-17_corrected.txt, which include the visit 
geometric mean values of the exposure and biomarker variables. The covariates used were 
current smoking status (C_Smoker), ethnicity (Ethnicity), visit geometric means of respiratory 
isocyanurate exposure after adjustment for the respiratory protection worn by the worker 
(DayISOP_APF_gm), and visit geometric means of isocyanurate skin exposure 
(DaySkin_ISO_gm). Current smoking status was coded as 0 for non-smoker and 1 for current 
smoker. Ethnicity was coded as 0 for Caucasian and 1 for other. 
 
Plink --bfile 56_final_10p_12Apr2015  --pheno Biomarker_LOD10+100gms_-4visits_-U65_03-
07-17_corrected.txt --pheno-name UTcr_TAHI_LOD100gm_-4visits_-U65 --pfilter 1e-3 --linear --
adjust --covar Covariates_03-17-17.txt --covar-name DayISOP_APF_gm, DaySkin_ISO_gm, 
Ethnicity, C_Smoker --out StudyISNPs_TAHI_UTcr_LOD100_gm_-4visits_covardaygm_03-17-17 
 
Subsequent GWAS mixed model analyses were performed in SAS using the statistically 
significant SNPs identified by this Plink code. 
 
Candidate Gene Analysis  
The following command provides statistical data on SNPs that are within +/- 20 kb of the 
candidate genes specified in SNPlist_2. 
 
Plink --bfile 56_final_10p_12Apr2015  --pheno Biomarker_LOD10+100gms_-4visits_-U65_03-
07-17_corrected.txt --pheno-name UTcr_TAHI_LOD100gm_-4visits_-U65 --linear --subset 
SNPlist_2.txt --set plink.set --covar Covariates_03-17-17.txt --covar-name 
DayISOP_APF_gm,DaySkin_ISO_gm,Ethnicity,C_Smoker --adjust --out UTcr_TAHIgenelist_03-17-
17 
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APPENDIX B: SAS CODE 
Test Normality of Datasets for Linear Regression  
/*Linear model data*/ 
title 'Normality of geometric mean of TAHI measurements'; 
proc univariate data=Linear_model_data plots normal; 
 var UTcr_TAHI_LOD100gm_4r; 
 qqplot;  
run; 
/*Mixed model data*/ 
title 'Normality of natural log-transformed TAHI measurements'; 
ods html; proc univariate data = Mixed_model_data plots normal; 
 var UTcr_TAHI_ln; 
label UTcr_TAHI_ln='Log-transformed urine day TAHI levels, adjusted for creatinine'; 
 qqplot;  
 run;  
 
title 'Normality of un-transformed TAHI measurements'; 
proc univariate data = Mixed_model_data plots normal; 
 var UTcr_TAHI; 
label UTcr_TAHI='Urine day TAHI levels, adjusted for creatinine'; 
 qqplot; 
run; 
 
Linear Models 
Macros for Running Linear Regressions 
 
%MACRO check_plink(snp= , filen=, marker=);  
/*Multiple regression with geometric mean values; run diagnostics on PLINK analyses*/  
 
proc glm data=&filen plots=(diagnostics(label) residuals); 
 class &snp; 
 model &marker=&snp C_Smoker DayISOP_APF_gm DaySkin_ISO_gm Ethnicity;  
 means &snp; 
output out=out_&snp rstudent=studresid predicted=predicted h=leverage cookd=inf 
predicted=fit residual=resid; 
 title "Association of &marker with &SNP"; 
title2 'Covariates: Current smoking status, air HDI isocyanurate (paint-time and APF-
adjusted), skin HDI isocyanurate, ethnicity'; 
run;  
 
proc sort data=out_&snp; 
 by descending inf ; run;  
  36 
proc print data=out_&snp (obs=5) label; 
 var iid inf &marker DayISOP_APF_m DaySkin_ISO_m; 
 label inf='D'; 
 label utcr_TAHI_LOD100gm_4r='GM log-urine TAHI, creatinine adj'   
 title "Cook's distance by worker with &SNP"; 
run;  
 
PROC MEANS data=&filen;  
 CLASS &SNP;  
 VAR &marker; 
RUN;  
 
PROC SGPLOT DATA=&filen; 
 VBOX &marker / CATEGORY=&SNP ; 
 title "Distribution of &marker"; 
RUN; 
 
Proc sgplot data=out_&snp; 
scatter y=resid x=fit / label=count; 
title "Predicted vs residuals, &snp"; 
run;  
 
Proc sgplot data=out_&snp; 
scatter y=studresid x=fit ; 
title "Predicted vs studentized residuals, &snp"; 
run;  
 
%MEND; 
 
%MACRO lev(snp= , filen=, marker=, pnum=, n=);  
/*calculate leverage for points in multiple regression with geometric mean values (checking 
PLINK analyses)*/ 
 
proc sort data=out_&snp; 
by descending leverage ; run;  
 
data out_l; 
set out_&snp (obs=10);  
p=&pnum; n=&n;  
F=((leverage-(1/n)/(p-1)))/((1-leverage)/(n-p)); 
pvalue=1-probf(F,p-1,n-p); 
if pvalue <=0.05/n then BONF="*"; 
else BONF=" "; *Bonferroni correction; 
  37 
label Bonf="Signif at 0.05/n?"; 
run; 
  
ods html; proc print data=out_l uniform label noobs; 
var count &marker &snp DayISOP_APF_gm DaySkin_ISO_gm leverage F pvalue Bonf; 
title "Leverage of data points, &marker"; 
run;  
%mend; 
 
Multiple Linear Regression Models 
 
ods graphics on;  
 
/*DIAGNOSTIC PLOTS FOR SIGNIFICANT SNP FOR URINE*/ 
%check_plink(snp= rs12955846, filen=Linear_model_data, marker=UTcr_TAHI_LOD100gm_4r)   
 
/*leverage*/ 
%lev(snp=rs12955846, filen=Linear_model_data, marker=UTcr_TAHI_LOD100gm_4r, n=31, 
pnum=7 ) 
 
Linear Mixed Effects Models 
ods rtf; PROC MIXED data=Mixed_model_data method=reml covtest;  
 CLASS IID rs12955846 visit; 
 MODEL UTcr_TAHI_ln = DayISOP_APF_ln DaySkin_ISO_ln rs12955846/ solution ; 
 repeated visit /type=cs subject=iid r rcorr; 
 title "Linear mixed effects model"; 
 title2 'Dependent variable: log total urine TAHI (creatine-adjusted)'; 
 title3 'Fixed effects: log air HDI isocyanurate (paint time, and APF-adjusted), log skin 
total HDI isocyanurate, Significant SNP'; run;  
 
Eigenanalysis for Collinearity  
/*correlations and principle components for cumulative exposure data*/ 
 
/*urine*/ 
proc princomp data= Linear_model_data noint ; 
 var rs12955846_new; run; 
proc corr data= Linear_model_data nosimple noprob ; 
 var rs12955846_new; run; 
/*********end correlations*********/ 
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